Caspofungin exposure-response relationships in adult patients with mucosal or invasive candidiasis-Reference-Cited by-同舟云学术

Caspofungin exposure-response relationships in adult patients with mucosal or invasive candidiasis

Published:2013-07-05 Issue:1 Volume:3 Page:43-50
ISSN:2160-763X
Container-title:Clinical Pharmacology in Drug Development
language:en
Short-container-title:

Author:

Comisar Wendy¹,Sun Peng¹²,Li Susan¹³,Sable Carole¹,Schwartz Michael¹,Bi Sheng¹,Chow Joseph¹⁴,Ngai Angela¹,Winchell Gregory¹,Kartsonis Nicholas¹,Stone Julie¹

Affiliation:

1. Merck Sharp & Dohme Corp.; Whitehouse Station NJ USA

2. GlaxoSmithKline; Collegeville PA USA

3. Johnson & Johnson; Wayne PA USA

4. AstraZeneca LP; Wilmington DE USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cpdd.44/fullpdf

Reference23 articles.

1. Opportunistic candidiasis: an epidemic of the 1980s;Fisher-Hoch;Clin Infect Dis.,1995

2. Clinical practice guidelines for the management of candidiasis: 2009 update by the infectious diseases Society of America;Pappas;Clin Infect Dis.,2009

3. A randomized double-blind study of caspofungin versus amphotericin for the treatment of candidal esophagitis;Villaneuva;Clin Infect Dis.,2001

4. Randomized, double-blind, multicenter study of caspofungin versus amphotericin B for treatment of oropharyngeal and esophageal candidiases;Arathoon;Antimicrob Agents Chemother.,2002

5. A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis;Villaneuva;Am J Med.,2002

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implications of Evolving and Emerging Pharmacokinetic-Pharmacodynamic Research for Triazoles and Echinocandins;Current Fungal Infection Reports;2020-05-19